| Pfizer AG - Bosulif 400 mg, Filmtabletten | | 62270 | | 03 | | Bosulif 400 mg | | Filmtabletten | | L01EA04 | | Bosutinib | | 04.02.2019 | | |
| | Composition | | bosutinibum 400 mg ut bosutinibum monohydricum, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 1.31 mg, poloxamerum 188, povidonum K 25, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 171, E 172 (rubrum), E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Bosutinibum | 400 mg |
| | BAG: Active Agent | Dose |
|---|
| Bosutinibum | 400 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | (Rubrum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Macrogol | 3350 | | | Magnesii Stearas | | | | Poloxamer | 188 | | | Poly(Alcohol Vinylicus) | | Überzug | | Povidonum K | 25 | | | Pro Compresso Obducto | | | | Talcum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | 28 | 2233.00 | 2389.95 | A | SL | Yes |
|
|
